A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Lyell Immunopharma, Inc.
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
St. Jude Children's Research Hospital
Artiva Biotherapeutics, Inc.
Baylor College of Medicine
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Malaghan Institute of Medical Research
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Essen Biotech
M.D. Anderson Cancer Center
Imugene Limited
University of California, San Francisco
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Sana Biotechnology
Case Comprehensive Cancer Center
Celgene
Thomas Jefferson University
Sana Biotechnology
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Acepodia Biotech, Inc.
Chinese PLA General Hospital
Massachusetts General Hospital
Case Comprehensive Cancer Center
Adicet Therapeutics
National Institutes of Health Clinical Center (CC)
Indapta Therapeutics, INC.
Thomas Jefferson University
Chinese PLA General Hospital
Chinese PLA General Hospital
CARGO Therapeutics
Miltenyi Biomedicine GmbH
University of Liverpool
Memorial Sloan Kettering Cancer Center
Caribou Biosciences, Inc.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Hoffmann-La Roche
University of Giessen
Celgene
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
M.D. Anderson Cancer Center
Chinese PLA General Hospital